卵磷脂络合碘在眼内出血性疾病中的应用观察  

clinical study of using iodized lecithin for hemorrhagic eye disease.

作　　者：张倩[1] 李莹[1] 黄丹琳[1] 刘艳[1] 

机构地区：[1]武警湖北省总队医院眼科,武汉430061

出　　处：《华中医学杂志》2007年第5期377-378,共2页Central China Medical Journal

摘　　要：目的观察卵磷脂络合碘治疗眼内出血性疾病的临床疗效。方法71例眼内出血性疾病患者按病因予以分类后均口服卵磷脂络合碘,用药时间4-20周,同时给予止血药及病因治疗。观察患者用药后的疗效。结果卵磷脂络合碘在各类眼内出血性疾病中应用的疗效均较好,有效率均在80%以上。在不同眼内出血性疾病中应用的疗效存在差异,疗效按病种由高到低依次为玻璃体出血/混浊、视网膜中央静脉阻塞、外伤及其他原因引起的眼底出血、视网膜分支静脉阻塞,其中玻璃体出血/混浊与视网膜分支静脉阻塞有效率比较,差异有极显著性。结论卵磷脂络合碘治疗眼内出血性疾病疗效满意,对眼底出血及玻璃体混浊有明显疗效,对眼底出血的吸收作用尤为明显,但没有预防再次出血的作用。Objective To observe clinical effect of iodized lecithin in the treatment of hemorrhagic eye disease. Methods Seventy-one cases with different hemorrhagic eye disease were treated with iodized lecithin, the treatment duration ranged from 4 to 20 weeks, and clinical effect were evaluated. Results Iodized lecithin was effective for all different hemorrhagic eye disease. the total efficacy rate were above 80%. But clinical effect were different in different diseases. There were significant difference between vitreous hemorrhage/opacity group and branch retinal vein occlusion group on efficacy rate. Conclusion Iodized lecithin has a satisfactory effect in the treatment of hemorrhagic eye disease, the treatment effect is obvious in subhyaloid hemorrhage or vitreous opacity patients. It can effectively accelerate the absorption of subhyaloid hemorrhage. But it has no prevention effect for rehemorrhage.

关 键 词：卵磷脂络合碘 玻璃体混浊 眼底出血 

分 类 号：R771[医药卫生—眼科]